Your browser is no longer supported. Please, upgrade your browser.
Settings
DXCM DexCom, Inc. daily Stock Chart
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-1.45 Insider Own1.20% Shs Outstand90.19M Perf Week-4.20%
Market Cap10.31B Forward P/E122.24 EPS next Y0.94 Insider Trans-16.95% Shs Float88.79M Perf Month-21.80%
Income-127.50M PEG- EPS next Q-0.16 Inst Own- Short Float6.22% Perf Quarter-23.55%
Sales1.03B P/S9.99 EPS this Y-324.80% Inst Trans0.03% Short Ratio4.01 Perf Half Y-14.20%
Book/sh7.47 P/B15.30 EPS next Y71.25% ROA-10.30% Target Price161.88 Perf Year55.50%
Cash/sh15.36 P/C7.44 EPS next 5Y- ROE-23.90% 52W Range72.04 - 156.16 Perf YTD-4.60%
Dividend- P/FCF183.74 EPS past 5Y-28.10% ROI-11.10% 52W High-26.81% Beta0.73
Dividend %- Quick Ratio7.30 Sales past 5Y45.20% Gross Margin64.40% 52W Low58.66% ATR5.20
Employees2800 Current Ratio7.60 Sales Q/Q52.90% Oper. Margin-18.10% RSI (14)35.49 Volatility4.51% 4.46%
OptionableYes Debt/Eq0.00 EPS Q/Q-283.00% Profit Margin-12.30% Rel Volume1.09 Prev Close111.38
ShortableYes LT Debt/Eq1.53 EarningsMay 01 AMC Payout- Avg Volume1.38M Price114.29
Recom1.90 SMA20-4.26% SMA50-15.24% SMA200-11.74% Volume1,508,733 Change2.61%
Nov-28-18Initiated UBS Neutral $135
Oct-19-18Upgrade Goldman Sell → Neutral
Sep-12-18Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18Reiterated Canaccord Genuity Buy $105 → $125
Jul-02-18Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18Upgrade JP Morgan Neutral → Overweight
May-11-18Initiated BofA/Merrill Buy $100
May-03-18Reiterated Canaccord Genuity Buy $81 → $85
Apr-04-18Initiated Guggenheim Neutral
Apr-04-18Initiated Goldman Sell $57
Mar-23-18Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17Reiterated Wedbush Outperform $85 → $76
Sep-28-17Downgrade Raymond James Outperform → Mkt Perform
Sep-28-17Downgrade Northland Capital Outperform → Market Perform
Sep-28-17Downgrade JP Morgan Overweight → Neutral
Sep-26-17Initiated Northland Capital Outperform $85
Sep-15-17Initiated Barclays Equal Weight $76
May-22-17Resumed Piper Jaffray Overweight
May-03-17Reiterated Canaccord Genuity Buy $95 → $90
Apr-20-19 05:00PM  How Marijuana Legalization Affected OrganiGram and Aphria's Latest Results Motley Fool
Apr-17-19 11:54AM  Abbott (ABT) Q1 Earnings Beat Estimates, Organic Sales Solid Zacks -5.42%
Apr-13-19 07:30PM  3 Top Diabetes Stocks to Watch in April Motley Fool
Apr-12-19 08:33AM  Top IoT Stocks to Buy in 2019 Motley Fool
Apr-11-19 05:45PM  DexCom (DXCM) Stock Moves 0.35%: What You Should Know Zacks
12:23PM  5 Top Medical Device Stocks for 2019 Motley Fool
Apr-05-19 05:45PM  DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Apr-04-19 09:12PM  Hedge Funds Havent Been This Bullish On DexCom, Inc. (DXCM) Since 2015 Insider Monkey
06:21PM  Here's Why DexCom Shares Slumped 14.5% in March Motley Fool
Apr-03-19 04:05PM  Dexcom Schedules First Quarter 2019 Earnings Release and Conference Call for May 1, 2019 at 4:30 p.m. Eastern Time Business Wire
Apr-01-19 10:58AM  Here's Why You Should Retain ABIOMED Stock in Your Portfolio Zacks
10:40AM  Integer Holdings Gets Positive Outlook & B+ Rating From S&P Zacks
Mar-27-19 08:34AM  Varian Medical (VAR) Collaborates With Korea-Based Hospital Zacks
Mar-26-19 12:00PM  Allscripts' FollowMyHealth Partners Ephraim McDowell Health Zacks
11:48AM  Fresenius Medical to Make Huge Investments, Competition Rife Zacks
Mar-25-19 10:53AM  AMN Healthcare Down on Soft Locum Tenens Business, Dull View Zacks
10:49AM  BD Remains Confident About LUTONIX DCB Despite FDA Letter Zacks
06:46AM  3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris InvestorPlace
Mar-23-19 09:30AM  DexCom (DXCM) Down 11.8% Since Last Earnings Report: Can It Rebound? Zacks
Mar-22-19 04:54PM  HMS Holdings Gains on PI & TPM Solutions, Competition Rife Zacks -9.24%
03:34PM  Here's Why You Should Retain Ecolab Stock in Your Portfolio Zacks
03:19PM  Here's Why DexCom Shares Are Dropping Today Motley Fool
10:33AM  DexCom, comScore, Lululemon, Nike and Under Armour highlighted as Zacks Bull and Bear of the Day Zacks
06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-21-19 04:28PM  Here's Why You Should Hold on to Cerner (CERN) Stock for Now Zacks
03:46PM  Spruce Point: Dexcom Could Fall 45-60% Benzinga
03:45PM  Heres What the Apple Watch Means for AAPL Stock InvestorPlace
Mar-20-19 09:30AM  Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
Mar-19-19 10:30AM  Inogen's Prospects in Europe Solid Amid Trade-Related Tension Zacks
Mar-18-19 09:08AM  Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4 Zacks
Mar-16-19 12:00PM  3 Top Diabetes Stocks to Watch in March Motley Fool
Mar-12-19 09:15AM  Tech Snaps Market Out of Slump Zacks
08:48AM  Varian & Tata Trust Tie Up to Boost Radiotherapy in India Zacks
07:00AM  The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom Zacks
Mar-11-19 09:19AM  The Best And Worst Stocks of the 10-Year Bull Market Zacks
08:48AM  HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick? Zacks
Mar-08-19 10:46AM  Is DexCom a Buy? Motley Fool
08:52AM  Align Technology-Benco Dental Deal to Expand iTero Reach Zacks
Mar-07-19 08:47AM  GNC Holdings to Expand Portfolio With Alani Nutrition Deal Zacks
08:38AM  Tandem's Global Growth a Boost, Operating Losses a Bane Zacks
Mar-06-19 08:57AM  GNC Forms Joint Venture With IVC to Improve Cost Efficiency Zacks
Mar-05-19 07:46AM  Here's Why You Must Add Hologic (HOLX) to Your Portfolio Now Zacks
07:42AM  Hologic (HOLX) Receives Global Nods for Omni Hysteroscope Zacks
Mar-04-19 08:31AM  Here's Why You Should Snap Up Abbott (ABT) Stock Right Now Zacks
Feb-28-19 11:49AM  Wait for the Inevitable Pullback to Buy TNDM Stock InvestorPlace
08:19AM  Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks
Feb-27-19 10:27AM  DexCom (DXCM) Gets Health Canada Approval for G6 CGM System Zacks
09:29AM  Chemed Gains Ground on Solid VITAS & Roto-Rooter Businesses Zacks
Feb-26-19 05:58PM  Here's Why Investors Should Buy DexCom (DXCM) Stock Now Zacks
07:25AM  Market Trends Toward New Normal in Infinera, Alliant Energy, Galectin Therapeutics, DexCom, Cutera, and Care Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-25-19 04:15PM  Dexcom Announces Upcoming Conference Presentation Business Wire
10:21AM  Edited Transcript of DXCM earnings conference call or presentation 21-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
08:25AM  DexCom's (DXCM) Q4 Earnings Beat, International Revenues Up Zacks
08:20AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
Feb-22-19 01:13PM  Dexcom G6® CGM System Receives Health Canada Approval CNW Group -6.42%
12:56AM  Dexcom Inc (DXCM) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-21-19 05:30PM  DexCom (DXCM) Q4 Earnings and Revenues Top Estimates Zacks
04:34PM  DexCom: 4Q Earnings Snapshot Associated Press
04:10PM  Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results Business Wire
07:49AM  Masimo and Saudi Arabia MOH Collaborate for CCHD Screening Zacks
07:16AM  Luminex Hurt By Segmental Sluggishness, Stiff Competition Zacks
Feb-15-19 02:00PM  The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings Benzinga
Feb-14-19 10:31AM  DexCom (DXCM) Earnings Expected to Grow: Should You Buy? Zacks
07:39AM  Here's Why Investors Should Buy CONMED (CNMD) Stock Now Zacks
Feb-13-19 12:38PM  Beating the Market With Medical-Device Stocks Barrons.com
08:12AM  DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-08-19 08:58AM  Ecolab (ECL) Reports Preliminary Q4 Results, Issues Guidance Zacks
08:37AM  Can TruBridge Fuel Computer Programs' (CPSI) Q4 Earnings? Zacks
Feb-07-19 09:34AM  BD Gains From Solid Global Base, Headwinds Anticipated Zacks
08:56AM  HealthEquity's (HQY) Preliminary Q4 Results Cheer Investors Zacks
Feb-05-19 09:12AM  3 Medical Instruments Stocks Likely to Beat Estimates in Q4 Zacks
Feb-04-19 06:59PM  Cramer Remix: Apple's next move in health care could be with Dexcom CNBC
03:49PM  Why DexCom Shares Soared 17.7% in January Motley Fool
08:57AM  Will Diagnostics Business Ail LabCorp (LH) in Q4 Earnings? Zacks
Feb-03-19 09:00AM  Better Buy: Abbott Laboratories vs. DexCom Motley Fool
Jan-31-19 10:58AM  Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth? Zacks
10:17AM  Can Molecular Diagnostics Drive Myriad's (MYGN) Q2 Earnings? Zacks
Jan-28-19 10:12AM  Cerner (CERN) to Report Q4 Earnings: What's in the Cards? Zacks
10:01AM  Can Zimmer Biomet (ZBH) Grow on Hip Business in Q4 Earnings? Zacks
09:48AM  Can CAG Growth Steadily Drive IDEXX (IDXX) in Q4 Earnings? Zacks
07:55AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings? Zacks
07:29AM  Will Core Business Units Boost McKesson's (MCK) Q3 Earnings? Zacks
Jan-25-19 09:10AM  ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates Zacks
08:53AM  AmerisourceBergen (ABC) Q1 Earnings: What's in the Cards? Zacks
08:12AM  What's in Store for Edwards Lifesciences' (EW) Q4 Earnings? Zacks
Jan-24-19 04:15PM  Dexcom Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for February 21, 2019 at 4:30 p.m. Eastern Time Business Wire
11:15AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q3 Earnings? Zacks
11:08AM  NextGen's (NXGN) Q3 Earnings Beat Estimates, Bookings Up Y/Y Zacks
10:19AM  What's Setting the Tone for Hologic's (HOLX) Q1 Earnings? Zacks
09:56AM  Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings? Zacks
09:54AM  Varian (VAR) Meets Q1 Earnings Estimates, Grows Globally Zacks
09:52AM  PetMed (PETS) Q3 Earnings Fall Y/Y, Reorder Sales Strong Zacks
02:43AM  Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid Zacks
Jan-23-19 09:16AM  Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q4 Earnings? Zacks
09:13AM  Can Overall Growth Fuel Align Technology's (ALGN) Q4 Earnings? Zacks
Jan-22-19 11:55AM  DexCom, Inc. (NASDAQ:DXCM): Time For A Financial Health Check Simply Wall St.
08:13AM  ResMed Launches Nasal Mask Devise, Extends AirFit Portfolio Zacks
Jan-21-19 07:56AM  Will Core MedSurg Segment Aid Stryker's (SYK) Q4 Earnings? Zacks
Jan-20-19 10:15AM  3 Healthcare Stocks Hitting 52-Week Highs: Are They Buys? Motley Fool
Jan-16-19 10:00AM  Here's Why Momentum Investors Will Love DexCom (DXCM) Zacks
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FOLETTA MARK GDirectorApr 15Sale118.981,000118,97714,095Apr 17 05:20 PM
SAYER KEVIN RPresident, CEO and ChairmanApr 15Sale118.916,000713,471306,100Apr 16 05:37 PM
Murphy Patrick MichaelSVP Legal AffairsApr 10Sale115.0540046,02036,260Apr 12 05:50 PM
ALTMAN STEVEN RDirectorApr 01Sale119.602,500298,99950,355Apr 02 07:09 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 25Sale127.382,016256,78912,096Mar 27 05:40 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 22Sale140.043,596503,57199,967Mar 26 06:25 PM
FOLETTA MARK GDirectorMar 15Sale150.281,000150,27915,095Mar 19 06:24 PM
Balo Andrew K*Mar 12Sale142.7910,9171,558,86277,217Mar 13 07:00 PM
Blackford Quentin S.EVP Chief Financial OfficerMar 12Sale142.795,358765,081100,614Mar 13 07:00 PM
DOUBLEDAY RICHARDEVP Chief Commercial OfficerMar 12Sale142.7910,8111,543,72672,570Mar 13 07:00 PM
Leach Jacob StevenEVP Chief Technology OfficerMar 12Sale142.798,5551,221,587116,083Mar 13 07:00 PM
MOY JEFFREYSVP OperationsMar 12Sale142.798,5311,218,16027,358Mar 13 07:01 PM
Murphy Patrick MichaelSVP Legal AffairsMar 12Sale142.793,962565,74336,660Mar 13 07:01 PM
Abbey DonaldEVP Quality and Regulatory AffMar 12Sale142.797,6531,092,78995,423Mar 13 06:59 PM
ACE HEATHER SSVP Human ResourcesMar 12Sale142.795,793827,19566,334Mar 13 07:00 PM
Pacelli Steven RobertEVP Strategy and Corporate DevMar 12Sale142.7910,8111,543,726103,913Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 12Sale142.7926,5663,793,418312,100Mar 13 07:01 PM
SAYER KEVIN RPresident, CEO and ChairmanMar 11Sale142.986,000857,890338,666Mar 13 07:01 PM
ACE HEATHER SSVP Human ResourcesMar 11Sale143.024,668667,63772,127Mar 13 07:00 PM
Murphy Patrick MichaelSVP Legal AffairsMar 08Sale141.5640056,62428,908Mar 11 08:46 PM
Pacelli Steven RobertEVP Strategy and Corporate DevFeb 22Sale144.671,667241,15799,737Feb 26 07:58 PM
FOLETTA MARK GDirectorFeb 15Sale148.721,000148,72316,095Feb 20 05:01 PM
SAYER KEVIN RPresident, CEO and ChairmanFeb 11Sale148.906,000893,400308,837Feb 13 07:23 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 04:46 PM
Murphy Patrick MichaelSVP Legal AffairsFeb 08Sale142.7640057,10429,308Feb 12 09:24 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jan 23Sale149.743,114466,303101,404Jan 24 05:46 PM
KAHN BARBARADirectorJan 14Sale142.3010,6311,512,82716,817Jan 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanJan 14Sale140.996,000845,930314,837Jan 15 05:30 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffJan 10Sale138.7540055,50029,708Jan 14 09:42 PM
SKYLER JAY SDirectorJan 02Option Exercise4.5825,806118,19152,616Jan 04 05:03 PM
ALTMAN STEVEN RDirectorJan 02Sale117.042,500292,59352,855Jan 04 05:03 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerDec 21Sale109.341,510165,10114,112Dec 26 08:33 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Dec 21Sale109.413,114340,700104,518Dec 26 08:22 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalDec 14Sale121.235,000606,16773,105Dec 18 06:34 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Option Exercise4.5811,16251,122331,999Dec 12 09:08 PM
SAYER KEVIN RPresident, CEO & ChairmanDec 10Sale121.6711,1621,358,041320,837Dec 12 09:08 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffDec 10Sale121.9040048,76030,108Dec 12 09:09 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerNov 23Sale121.351,736210,66415,622Nov 27 06:27 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Nov 23Sale121.423,114378,105107,632Nov 27 06:27 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalNov 14Sale143.135,000715,66478,105Nov 16 05:14 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Option Exercise4.5811,16151,117331,998Nov 14 07:29 PM
SAYER KEVIN RPresident, CEO & ChairmanNov 12Sale146.4311,1611,634,284320,837Nov 14 07:29 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffNov 09Sale148.1140059,24430,508Nov 13 08:14 PM
Abbey DonaldEVP, Quality & Regulatory AfrsNov 09Sale149.3010,5501,575,15988,089Nov 13 08:13 PM
ACE HEATHER SSVP Human ResourcesNov 09Sale147.324,258627,29465,081Nov 13 08:14 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Oct 23Sale128.853,114401,253110,746Oct 25 08:58 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerOct 23Sale128.721,736223,46617,358Oct 25 08:59 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalOct 12Sale124.795,000623,93483,105Oct 16 05:27 PM
Murphy Patrick MichaelSVP, GC & Chief Compliance OffOct 10Sale122.2040048,88030,908Oct 12 04:11 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Option Exercise4.5811,16151,117331,998Oct 10 07:48 PM
SAYER KEVIN RPresident, CEO & ChairmanOct 08Sale124.7611,1611,392,433320,837Oct 10 07:48 PM
ALTMAN STEVEN RDirectorOct 01Sale135.652,500339,13455,355Oct 03 04:50 PM
Leach Jacob StevenChief Technology OfficerSep 28Sale143.9547,6006,852,1390Oct 01 07:10 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 24Sale141.201,736245,12919,094Sep 26 08:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 24Sale141.253,114439,841113,860Sep 26 08:32 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 14Sale145.175,000725,85188,105Sep 18 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 12Option Exercise5.9215,00088,800109,284Sep 14 04:35 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 11Sale147.048,4401,241,02887,131Sep 13 09:48 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Option Exercise4.5811,16151,117346,332Sep 12 09:17 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerSep 10Sale143.765,483788,21066,804Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.355,736822,25616,711Sep 12 09:22 PM
MOY JEFFREYSVP, OperationsSep 10Sale143.764,594660,41163,920Sep 12 09:22 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrSep 10Sale143.692,372340,82531,308Sep 12 09:20 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 10Sale143.765,483788,210116,974Sep 12 09:21 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalSep 10Sale143.765,587803,16093,105Sep 12 09:21 PM
ACE HEATHER SSVP Human ResourcesSep 10Sale143.761,832263,36069,339Sep 12 09:19 PM
Leach Jacob StevenSVP, Research & DevelopmentSep 10Sale143.764,614663,28694,284Sep 12 09:20 PM
Abbey DonaldEVP, Quality & Regulatory AfrsSep 10Sale143.762,303331,06898,639Sep 12 09:19 PM
Blackford Quentin S.EVP, CFO, PFO & PAOSep 10Sale143.767,1491,027,70695,571Sep 12 09:18 PM
SAYER KEVIN RPresident, CEO & ChairmanSep 10Sale143.6225,4953,661,573320,837Sep 12 09:17 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Option Exercise4.5220,57792,941109,455Aug 28 06:58 PM
ALTMAN STEVEN RDirectorAug 24Sale136.475,000682,3590Aug 28 08:32 PM
FOLETTA MARK GDirectorAug 24Sale137.501,000137,50317,095Aug 28 07:01 PM
Leach Jacob StevenSVP, Research & DevelopmentAug 24Sale138.3220,5772,846,15598,878Aug 28 06:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 23Sale139.963,114435,843122,457Aug 27 05:20 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerAug 23Sale140.032,584361,8330Aug 27 05:20 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalAug 14Sale124.255,000621,25398,567Aug 16 06:08 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Option Exercise4.5811,16151,117346,332Aug 15 05:15 PM
SAYER KEVIN RPresident, CEO & ChairmanAug 13Sale123.2211,1611,375,211335,171Aug 15 05:15 PM
Murphy Patrick MichaelVP, Legal Aff & Chf Compl OfcrAug 10Sale124.1812,5001,552,31033,680Aug 14 08:32 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.773,230393,30114,362Aug 08 08:33 PM
AUGUSTINOS NICHOLASDirectorAug 06Sale121.189,0701,099,0807,802Aug 08 08:33 PM
MOY JEFFREYSVP, OperationsAug 01Sale94.135,831548,8725,061Aug 03 04:50 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 25Sale101.913,114317,335125,571Jul 27 05:09 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJul 23Sale102.482,581264,5131,067Jul 25 07:54 PM
GREGG TERRANCE HExecutive ChairmanJul 16Sale99.5610,000995,56150,882Jul 18 05:50 PM
Balo Andrew KEVP, Reg. Strategy, ClinicalJul 16Sale99.565,000497,816103,567Jul 18 05:50 PM
SAYER KEVIN RPresident & CEOJul 09Sale99.7914,2191,418,856335,171Jul 11 09:07 PM
MOY JEFFREYSVP, OperationsJun 28Sale92.4859,1935,474,29710,892Jul 02 08:51 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerJun 25Sale98.582,581254,4313,648Jun 26 08:26 PM
GREGG TERRANCE HExecutive ChairmanJun 15Sale97.8110,000978,096882Jun 19 08:37 PM
TOPOL ERICDirectorJun 12Sale100.1020,0002,001,99884,562Jun 13 08:19 PM
DOUBLEDAY RICHARDEVP, Chief Commercial OfficerMay 23Sale86.002,581221,9636,229May 25 07:52 PM
GREGG TERRANCE HExecutive ChairmanMay 15Sale85.9010,000858,974882May 17 06:49 PM
SKYLER JAY SDirectorMay 14Option Exercise4.5830,000137,40052,257May 16 08:00 PM
SKYLER JAY SDirectorMay 14Sale88.0030,0002,640,00022,257May 16 08:00 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.May 10Option Exercise7.632,85521,784128,685May 11 08:03 PM
SAYER KEVIN RPresident & CEOMay 09Option Exercise7.6331,464240,070366,635May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Option Exercise9.728,74585,017107,420May 10 07:54 PM
Leach Jacob StevenSVP, Research & DevelopmentMay 09Sale84.778,745741,32898,878May 10 07:54 PM